financetom
Business
financetom
/
Business
/
Repsol weighs merger of upstream unit with APA, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Repsol weighs merger of upstream unit with APA, Bloomberg News reports
Nov 13, 2025 9:49 AM

Nov 13 (Reuters) - Spain's biggest refinery operator

Repsol SA is considering a reverse merger of its

upstream unit with potential partners, including U.S. energy

producer APA, Bloomberg News reported on Thursday,

citing people with knowledge of the matter.

APA shares were up 7.1% at $25.59.

Repsol in 2022 entered into a deal to sell a 25% stake in

the upstream division to private equity firm EIG Global Energy

Partners, valuing the whole business around that time at $19

billion including debt.

The upstream unit has net hydrocarbon production of about

571,000 barrels of oil equivalent per day, according to the

company website.

The report comes weeks after Repsol CEO Josu Jon Imaz said

the upstream unit was being prepared for a liquidity event in

2026, which could mean an IPO or a reverse merger with a company

listed in the U.S.

The Spanish company has held exploratory discussions with

potential merger partners for the business, including APA, the

Bloomberg report said.

An APA spokesperson declined Reuters request for comment,

while Repsol did not immediately respond.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boundless Bio to Discontinue Clinical Trial Related to Solid Tumors
Boundless Bio to Discontinue Clinical Trial Related to Solid Tumors
Dec 12, 2024
05:51 PM EST, 12/12/2024 (MT Newswires) -- Boundless Bio ( BOLD ) said late Thursday it made a strategic decision not to continue dose escalation of Part 1 or proceed into the Part 2 portion of a clinical trial for the oral inhibitor BBI-825 in patients with solid tumors. The decision follows an assessment of preliminary pharmacokinetic data showing a...
Upbound Group Agrees to Acquire Brigit for up to $460 Million
Upbound Group Agrees to Acquire Brigit for up to $460 Million
Dec 12, 2024
05:52 PM EST, 12/12/2024 (MT Newswires) -- Upbound Group ( UPBD ) said Thursday it agreed to acquire Brigit for up to $460 million in cash and shares. The transaction includes $325 million payable at closing, comprising 75% cash and 25% shares, and $75 million deferred cash consideration over two years, Upbound added. Additionally, the deal includes a potential earnout...
Gilead appoints Sanofi official Dietmar Berger as next chief medical officer
Gilead appoints Sanofi official Dietmar Berger as next chief medical officer
Dec 12, 2024
Dec 12 (Reuters) - Gilead Sciences ( GILD ) said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who prepares to leave early next year. Berger, who will join on Jan. 2, is French pharmaceutical giant Sanofi's current chief medical officer. ...
Deckers Outdoor Insider Sold Shares Worth $2,973,845, According to a Recent SEC Filing
Deckers Outdoor Insider Sold Shares Worth $2,973,845, According to a Recent SEC Filing
Dec 12, 2024
05:47 PM EST, 12/12/2024 (MT Newswires) -- Caroti Stefano, President & CEO, on December 11, 2024, sold 14,274 shares in Deckers Outdoor ( DECK ) for $2,973,845. Following the Form 4 filing with the SEC, Stefano has control over a total of 259,266 shares of the company, with 259,266 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/910521/000159396824001470/xslF345X05/primary_01.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved